» Authors » Rachel Scagos

Rachel Scagos

Explore the profile of Rachel Scagos including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 36
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Siegert T, Chambers L, Weidele H, Scagos R, McDonald J, Onyejekwe C, et al.
Subst Use Misuse . 2022 Oct; 57(14):2142-2145. PMID: 36305842
Accidental opioid-involved overdose deaths are increasing nationally in the wake of the COVID-19 pandemic, but it is unclear if this reflects a change in populations most at risk. To determine...
2.
King E, Marchetti L, Weidele H, Wolanski J, Shrestha N, St John K, et al.
Addiction . 2022 Apr; 117(9):2464-2470. PMID: 35434861
Background And Aims: Opioids biosurveillance is a new approach to public health surveillance of non-fatal overdoses that relies upon laboratory analysis of residual biospecimens from hospitals treating opioids overdoses. In...
3.
Schell R, Allen B, Goedel W, Hallowell B, Scagos R, Li Y, et al.
Am J Epidemiol . 2022 Jan; 191(3):526-533. PMID: 35020782
Predictors of opioid overdose death in neighborhoods are important to identify, both to understand characteristics of high-risk areas and to prioritize limited prevention and intervention resources. Machine learning methods could...
4.
Wightman R, Perrone J, Scagos R, Hallowell B, Krieger M, Li Y, et al.
Drug Alcohol Depend . 2021 Sep; 227:108994. PMID: 34482038
Intro: Understanding sex differences in toxicological etiologies of opioid-related drug overdose death could inform future sex- and gender-specific approaches to prevention and treatment. Methods: A retrospective review of accidental or...
5.
Wightman R, Perrone J, Scagos R, Krieger M, Nelson L, Marshall B
J Med Toxicol . 2020 Jul; 17(1):10-15. PMID: 32648229
Background: Buprenorphine is a unique μ-opioid receptor partial agonist with avid receptor binding, nominal euphoric reward, and a ceiling effect on sedation and respiratory depression. Despite a pharmacologic profile that...